Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study-Reference-Cited by-同舟云学术

Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study

Published:2014-05 Issue:5 Volume:14 Page:388-396
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Gray Glenda E,Moodie Zoe,Metch Barbara,Gilbert Peter B,Bekker Linda-Gail,Churchyard Gavin,Nchabeleng Maphoshane,Mlisana Koleka,Laher Fatima,Roux Surita,Mngadi Kathryn,Innes Craig,Mathebula Matsontso,Allen Mary,McElrath M Julie,Robertson Michael,Kublin James,Corey Lawrence

Funder

National Institute of Allergy and Infectious Diseases to the HIV Vaccine Trials Network

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference37 articles.

1. Novel adenovirus vector-based vaccines for HIV-1;Barouch;Curr Opin HIV AIDS,2010

2. Biodistribution and Toxicological Safety of Adenovirus Type 5 and Type 35 Vectored Vaccines Against Human Immunodeficiency Virus-1 (HIV-1), Ebola, or Marburg Are Similar Despite Differing Adenovirus Serotype Vector, Manufacturer's Construct, or Gene Inserts

3. Magnitude and phenotype of cellular immune responses elicited by recombinant adenovirus vectors and heterologous prime-boost regimens in rhesus monkeys;Liu;J Virol,2008

4. Broad cellular immunity with robust memory responses to simian immunodeficiency virus following serial vaccination with adenovirus 5- and 35-based vectors;Barratt-Boyes;J Gen Virol,2006

5. Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primates;Santra;J Virol,2005

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV Vaccine Development at a Crossroads: New B and T Cell Approaches;Vaccines;2024-09-12

2. Human Immunodeficiency Virus Vaccine;Infectious Disease Clinics of North America;2024-09

3. A J Paramyxovirus-vectored HIV vaccine induces humoral and cellular responses in mice;Vaccine;2024-04

4. Exploring HIV Vaccine Progress in the Pre-Clinical and Clinical Setting: From History to Future Prospects;Viruses;2024-02-27

5. Adenovirus-vectored PDCoV vaccines induce potent humoral and cellular immune responses in mice;Vaccine;2023-10